Metal Complexes as Antiviral Agents for SARS-CoV-2

Area of Science:

• Medicinal Chemistry
• Virology
• Inorganic Chemistry

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in millions of deaths globally.
• Despite vaccine development, there is a critical need for effective antiviral therapies.
• Metal complexes are being explored as alternative therapeutic agents against viral infections.

Purpose of the Study:

• To review metal complexes with demonstrated antiviral activity against SARS-CoV-2.
• To discuss the proposed mechanisms of action for these metal-based antiviral agents.
• To highlight the potential of metal complexes in combating SARS-CoV-2 and future viral threats.

Main Methods:

• Literature review of scientific publications.
• Analysis of studies reporting antiviral activity of metal complexes against SARS-CoV-2.
• Examination of proposed mechanisms of action for identified compounds.

Main Results:

• Several metal complexes have shown significant antiviral activity against SARS-CoV-2 in vitro.
• These complexes target various stages of the viral life cycle or host cell interactions.
• Mechanisms include inhibition of viral entry, replication, or enzyme activity.

Conclusions:

• Metal complexes represent a promising class of compounds for developing novel antiviral drugs against SARS-CoV-2.
• Further research into their efficacy, safety, and mechanisms is warranted.
• Metal-based therapies could offer alternative treatment strategies for COVID-19 and other viral diseases.